Cargando…
PRISMA-combined α-blockers and antimuscarinics for ureteral stent-related symptoms: A meta-analysis
BACKGROUND: As a monotherpay, a-blockers and anti-muscarinics are both efficacy for ureteral stent-related symptoms (SRS). The aim of the study was to systematically evaluate their efficacy of a combination therapy for SRS. METHODS: Relevant studies investigating α-blockers and/or anti-muscarinics f...
Autores principales: | Zhang, Yu-ming, Chu, Pei, Wang, Wen-jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5319511/ https://www.ncbi.nlm.nih.gov/pubmed/28207522 http://dx.doi.org/10.1097/MD.0000000000006098 |
Ejemplares similares
-
High satisfaction with direct switching from antimuscarinics to mirabegron in patients receiving stable antimuscarinic treatment
por: Liao, Chun-Hou, et al.
Publicado: (2016) -
Systematic review and meta-analysis of the efficacy and safety of vibegron vs antimuscarinic monotherapy for overactive bladder
por: Su, Shunye, et al.
Publicado: (2021) -
Effect of magnesium sulfate on renal colic pain: A PRISMA-compliant meta-analysis
por: Chen, Liang-Fu, et al.
Publicado: (2020) -
The efficacy and safety of alpha-adrenergic blockers for medical expulsion therapy in patients with ureteral calculi: A meta-analysis of placebo-controlled trials
por: Yu, Ze-Wei, et al.
Publicado: (2021) -
Pooled analysis of efficacy and safety of ureteral stent removal using an extraction string
por: Sun, Xujie, et al.
Publicado: (2019)